Idan ka sha man kifi kana fatan zai ƙarfafa ƙasusuwa, ɗaya daga cikin manyan gwaje‑gwajen da aka taƙaita kan wannan batu ya kawo wasu sakamakon da ba su da kyau. A wani bincike da ya haɗa da mutane 25,871 masu lafiya gaba ɗaya, ƙarin omega‑3 daga teku ba su rage haɗarin fashe‑fashe ba. Kawai canjin ƙaramin ƙimar ƙazamar ƙashi ne aka gani, kuma ya bayyana ne a auna guda ɗaya.
Sakamakon na fitowa ne daga wani ƙaramin bincike na VITamin D and OmegA‑3 TriaL (VITAL), wanda aka wallafa a Journal of Bone and Mineral Research a shekarar 2026.
Tallan Man Kifi: Me Ya Sa Ake Zaton Zai Taimaka Ga Kashi?
Manufar ba ta da rashin ma'ana. Mawallafa sun lura da cewa gwaje‑gwajen dabbobi da na dakin gwaje‑gwaje suna nuna cewa omega‑3 na iya amfanar lafiyar ƙashi. Irin waɗannan shaidu na dabbobi suna ƙara ƙwarin gwiwa, amma sau da yawa ba su iya kaiwa ga mutane. Takardar ta kuma nuna cewa ƙananan gwaje‑gwajen da suka yi amfani da omega‑3 a kan sakamakon ƙashi a mutane ba su da yawa. Wannan gwajin an tsara shi don cike wannan gibin.
Yadda Gwajin Ya Gudana
VITAL gwaji ne mai tsarin 2 × 2 factorial, an raba mutane ba tare da sani ba, an ba su placebo ko kuma ɗayan sinadaran. An gwada omega‑3 na teku, bitamin D3, duka biyun, ko placebo. Asalin manufar ita ce tantance tasirin su kan cutar kansa da na zuciya. Binciken ƙashi kuwa na ƙaramin ɓangare ne na wannan babban gwaji.
Muhimman bayanai:
- Kwayar: gram 1 a kowace rana na omega‑3 na teku, tare da EPA da DHA a cikin ƙididdiga 1.2:1
- Masu halarta: mutane 25,871 daga Amurka – maza masu shekara 50 ko sama da haka da mata masu shekara 55 ko sama da haka
- Kauracewa: waɗanda ke da cutar kansa ko cutar zuciya a lokacin ɗaukar su ba a haɗa su ba
- Zaɓi: ba a zaɓi masu halarta bisa ga ƙarancin ƙashi ko tarihin fashe‑fashe ba
- Lokaci: an gudanar da gwajin daga Nuwamba 2011 zuwa Disamba 2017, tare da matsakaicin bin diddigi na shekaru 5.3
- Matsakaicin shekaru: 67.1
Manufar farko ita ce tantance yawan fashe‑fashe na gabaɗaya, waɗanda ba na ƙashin bayani ba, da na ƙugu a dukkan rukunin. A cikin ƙaramin ɓangaren mutane 771, an auna canjin ƙimar ƙazamar ƙashi da tsarin su na tsawon shekaru 2. An yi amfani da DXA don auna areal bone mineral density (aBMD) kuma an yi amfani da peripheral quantitative CT don auna volumetric BMD, kaurin cortical, da ƙididdigar ƙarfafa ƙashi a radius da tibia.
Sakamakon Fashe‑Fashe: Ba Wani Banbanci
Omega‑3 bai rage fashe‑fashe na kowanne iri da aka auna ba:
- Fashe‑fashe na gabaɗaya: HR 1.02 (95% CI 0.92–1.13; p = .73)
- Fashe‑fashe marasa ƙashin bayani: HR 1.01 (95% CI 0.91–1.12; p = .80)
- Fashe‑fashe na ƙugu: HR 0.89 (95% CI 0.61–1.30; p = .55)
Idan HR ta kai 1.0, ba a samu bambanci tsakanin ƙungiyoyi. Lambobin gabaɗaya da na marasa ƙashin bayani suna nan a kusan 1.0. Kodayake HR na ƙugu ya kasance ƙasa da 1 (0.89), tazara ta amincewa (confidence interval) ta haɗa da 1 (0.61–1.30) kuma p‑value na .55, wanda ke nuni da babu wani tasiri.
Sakamakon Ƙimar Ƙazamar Kashi: Ɗan Ƙaramin Canji
A cikin ƙungiyar mutane 771, aBMD na gaba ɗaya ya ƙaru da +0.03% a ƙungiyar omega‑3, yayin da a ƙungiyar placebo ya ragu da ‑0.41% (p = .006). Mawallafa sun kira wannan da ƙaramin ƙaruwa.
Komai sauran ya kasance babu tasiri. Ba a sami canji a aBMD na kashin bayani ko na ƙugu ba. Ba a sami tasiri a volumetric BMD ko a ƙididdigar ƙarfafa ƙashi a radius ko tibia ba. Ƙaramin canjin gaba ɗaya ba tare da wani ingantaccen canji a wuraren da suka fi shafar fashe‑fashe ba, ba zai iya zama hujja ta kariya ba. Hakanan, an gwada manyan ma'auni da yawa, don haka ɗaya kawai daga cikin su da ya nuna sakamako mai kyau ya kamata a ɗauki hankali.
Shin Wannan Ya Na da Amfani Ga Lafiya?
Ba a lura da wani mummunan tasiri ba. Don haka, ba wai man kifi ya cutar da ƙashi ba, sai dai bai taimaka ba a wannan rukunin mutane.
Me Wannan Ke Nufi A Garinku
Waɗanda sakamakon ya shafa: Mutane masu lafiya a al'umma, masu shekaru tsaka‑tsaki zuwa manya, waɗanda ba a zaɓe su don ƙarancin ƙashi ko tarihin fashe‑fashe ba. Gwajin ba zai iya faɗi ko omega‑3 na taimakawa ga masu cutar osteoporosis, ko ga waɗanda ke da haɗarin fashe‑fashe sosai, ko ga waɗanda ke da wasu cututtuka ba. Hakanan, an gwada kawai gram 1 a rana na EPA + DHA, don haka sauran ƙididdiga ba a gwada su ba.
Abubuwan da za ku iya ɗauka:
- Kada ku jingina ga man kifi a matsayin dabarar kariya ga ƙashi. A wannan gwajin, gram 1 a rana tsawon shekaru 5.3 ba su rage fashe‑fashe ba.
- Kada ku yi tsammanin ƙaruwa a ƙimar ƙashi. Canjin da aka gani ƙanana ne kuma a jikin gaba ɗaya, ba a spine, ƙugu, radius ko tibia ba.
- Lokacin shan ba zai magance ba. An yi amfani da shan kullum, kuma ba a sami fa'ida ba; ba mu da hujja cewa canza lokaci zai sauya sakamakon.
- Idan kun riga kun sha don wasu dalilai, wannan binciken ba ya nuna cutarwa ga ƙashi. Omega‑3 na da amfani ga wasu cututtuka, amma waɗannan ba su cikin wannan takarda. Ku tattauna da likitan ku don sanin yadda ya dace da ku.
- Idan lafiyar ƙashi ke damunku, nemi hanyoyi da ke da ƙarfi a hujjoji. Wadannan ba su cikin wannan takarda.
Abubuwan Da Ya Kamata Ku Sani
Auna ƙazamar ƙashi ya ɗauki shekaru 2 kawai a cikin mutane 771, don haka wannan ɓangaren ƙanana ne idan aka kwatanta da nazarin fashe‑fashe. Masu halarta sun kasance masu lafiya gaba ɗaya, ba a zaɓe su bisa ga haɗarin ƙashi ba, wanda ke iyakance abin da gwajin zai iya faɗi game da ƙungiyoyi masu haɗari. A cikin bayanin bayyana masu hannu, an ambaci ɗaya daga cikin marubuta da ke da alaka ta kuɗi da Pharmavite.
Takaitaccen Bayani
Dalilin da ya sa masana suka yi tunanin omega‑3 na taimakawa ƙashi ya kasance mai ma'ana a dabbobi da dakin gwaje‑gwaje, amma a cikin mutane, gwaji mai girma da ƙaƙƙarfan tsari bai tabbatar da hakan ba. Mawallafa sun kammala da cewa ƙarin omega‑3 na teku ba ya rage haɗarin fashe‑fashe kuma ba ya da wani tasiri a kan aBMD ko ƙarfafa ƙashi, banda ƙaramin ƙaruwa a aBMD na gaba ɗaya. Don kariyar ƙashi, man kifi ba ya bayyana a matsayin amsar da ake nema.